MEDIBIO LIMITED (MEB)

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Christopher Ntoumenopoulos Director
Transaction date
Purchase
Price
217.98
Quantity 99,814
Value A$3,212,486
David Trimboli Director
Transaction date
Purchase
Price
455.95
Quantity 30,083
Value A$162,695
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-10-16 2023-10-13 B Purchase Christopher Ntoumenopoulos Director
99,814
217.98
A$3,212,486
99,814 217.98 A$3,212,486
2023-10-16 2023-10-13 B Purchase David Trimboli Director
30,083
455.95
A$162,695
30,083 455.95 A$162,695
Explore more

More insider trading research around MEDIBIO LIMITED